Call for Final Rule
With Medicaid reimbursements representing a significant portion of a pharmacy’s profit, all retail pharmacy organizations are waiting for a final rule to be put in place as created by the Deficit Reduction Act of 2005 (DRA) and later the health care reform act on how reimbursement rates are set. These laws state that the average manufacturer price (AMP) is used to set the Federal Upper Limits (FUL) for generic drugs in the Medicaid program. The intent of Congress was to pay ...
SIGN IN TO ACCESS THIS ARTICLE
Registering for Premium Content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.